1. Pink Sheet

Califf: More Expedited Approvals Mean US Clearance Only The Beginning Of Learning About Medical Products

 
• By Derrick Gingery

The US FDA commissioner said increased use of expedited approval pathways will help spur clinical research system reform.

Califf speaks to DIA
FDA Commissioner Robert Califf spoke at the DIA Global Annual Meeting in Chicago via video. • Source: Derrick Gingery

CHICAGO – Robert Califf expects sponsors likely will have to adapt development programs to the level of evidence available upon marketing clearance if expedited pathways become even more of the norm.

Califf, US Food and Drug Administration Commissioner, envisions pre-approval development as only the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D